BRIEF-AbbVie Submits New Drug Application To FDA For Investigational ABBV-951 For Treatment Of Advanced Parkinson's Disease
* ABBVIE SUBMITS NEW DRUG APPLICATION TO U.S. FDA FOR INVESTIGATIONAL ABBV-951 (FOSCARBIDOPA/FOSLEVODOPA) FOR THE TREATMENT OF ADVANCED PARKINSON'S DISEASE
* ABBVIE INC (ABBV) - WILL CONTINUE TO PURSUE REGULATORY SUBMISSIONS FOR ABBV-951 ACROSS INTERNATIONAL MARKETS THROUGHOUT YEAR Source text for Eikon: Further company coverage: